Chronic cough, defined as a cough persisting for more than eight weeks, is a common yet challenging condition faced by clinicians. Despite its prevalence, the diagnosis and management of chronic cough can be complex due to its multifactorial etiology and the need for a comprehensive, patient-centered approach.
Chronic cough is often a symptom of underlying conditions such as asthma, gastroesophageal reflux disease (GERD), and upper airway cough syndrome (UACS). However, in some cases, it may also be idiopathic. Understanding the pathophysiology and conducting a thorough patient history and physical examination are crucial first steps in diagnosis. Laboratory tests, imaging studies, and specialized procedures may also be utilized as needed.
Effective management of chronic cough involves treating the underlying cause, alleviating symptoms, and improving quality of life. Pharmacological interventions, such as bronchodilators, inhaled corticosteroids, and proton pump inhibitors, may be employed depending on the identified cause. Non-pharmacological approaches, including behavioral therapy and physiotherapy, may also be beneficial.
Given the heterogeneous nature of chronic cough, a personalized approach is essential. This involves understanding the patient's unique circumstances, including their medical history, lifestyle, and preferences. A multidisciplinary team involving pulmonologists, gastroenterologists, otolaryngologists, and allied health professionals can provide a comprehensive and coordinated care plan.
In conclusion, chronic cough is a complex condition that requires a comprehensive and personalized approach in clinical practice. By understanding the pathophysiology, conducting a thorough diagnosis, and employing effective management strategies, clinicians can improve patient outcomes and quality of life.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation